Description
Leflunomideinhibitsdihydroorotatedehydrogenase,preventingUMPformationandpyrimidinesynthesis.MetabolitesofleflunomidemayinhibitvariouskinasessuchasJNKandJAK.Leflunomideisclinicallyusedtotreatrheumatoidarthritis;itexhibitsimmunosuppressive,antiviral,andanticanceractivities.Inseveralcellularmodels,leflunomidepreventsapoptosisandincreasesviABIlityinhumancytomegalovirus(CMV)-infectedcellsandinhibitsreplicationofpolyomavirusBK.Additionally,leflunomideincreasesactivityofarylhydrocarbonreceptors,inhibitingproliferationofmelanomacells.
References
QiR,Hua-SongZ,Xiao-FengZ.Leflunomideinhibitstheapoptosisofhumanembryoniclungfibroblastsinfectedbyhumancytomegalovirus.EurJMedRes.2013Feb1;18:3.PMID:23369524.
O"DonnellEF,KopparapuPR,KochDC,etal.Thearylhydrocarbonreceptormediatesleflunomide-inducedgrowthinhibitionofmelanomacells.PLoSOne.2012;7(7):e40926.PMID:22815870.
BernhoffE,TyldenGD,KjerpesethLJ,etal.LeflunomideinhibitionofBKvirusreplicationinrenaltubularepithelialcells.JVirol.2010Feb;84(4):2150-6.PMID:19955306.
PintoP,DougadosM.Leflunomideinclinicalpractice.ActaReumatolPort.2006Jul-Sep;31(3):215-24.PMID:17094333.